Hydroxy-PP-Me

Overview

Hydroxy-PP-Me is a selective CBR1 inhibitor with an IC 50 of 759 nM. Hydroxy-PP-Me can inhibit serum starvation-induced apoptosis . Hydroxy-PP-Me can enhance the cytotoxic effects of Daunorubicin ( HY-13062A ) and As 2 O 3 on tumor cells. Hydroxy-PP-Me can be used in the research of cancer such as leukemia.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > NADPH Oxidase | Products > Signaling Pathways > Reactive Oxygen Species (ROS)

Product Information

• Catalog No.: HY-156694
• CAS No.: 833481-77-9
• Molecular Formula: C16H18N4O
• Molecular Weight: 282.34
• Purity: 98.62%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (8.85 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source